Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery [Phase 3]

View source ↗

Summary

Phase 3 multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of the Sufentanil NanoTab PCA System (Zalviso) for po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Sufentanil NanoTab PCA System (Zalviso) (sufentanil)

Snippet

Sponsor: Talphera, Inc | Conditions: Post-Operative Pain | Phase 3 | Status: COMPLETED | Results posted: 2014-02-03